lumos.png
Lumos Pharma Reports Third Quarter 2021 Financial Results and Provides Clinical Updates
November 03, 2021 16:01 ET | Lumos Pharma, Inc.
Majority of OraGrowtH210 Trial sites are open with recent and imminent openings representing historically high enrollment sitesSix-month primary outcome data readout from OraGrowtH210 expected 2H 2023...
TIP_link_300x300.jpg
Encapsulation Market Size ($80,071.65Mn by 2028) Driven by Food and Beverages (12.5% CAGR) Impact of Coronavirus Outbreak and Global Analysis & Forecast by TheInsightPartners.com
November 03, 2021 14:46 ET | The Insight Partners
New York, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Encapsulation Market: Key InsightsAccording to our new research study on Encapsulation Market Size, Share, Revenue, Forecast to 2028 - COVID-19 Impact and...
researchdrivelogo.jpg
Industry Dynamics: Mass Transfer Equipment Market Expected to Generate a Revenue of $4,599.2 Million by 2026, Surging at a CAGR of 7.1% from 2021-2022 – Exclusive Report [150 Pages] By Research Dive
November 03, 2021 09:00 ET | Research Dive
New York, USA, Nov. 03, 2021 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global mass transfer equipment market is expected to garner a revenue of $4,599.2 million by...
Jean-Baptiste Agnus Headshot
AGC Biologics Appoints Jean-Baptiste Agnus as Chief Business Officer
November 01, 2021 09:03 ET | AGC Biologics
Seattle, Nov. 01, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced Jean-Baptiste Agnus has been...
Paul Mueller Company Logo
Paul Mueller Company Announces Its Third Quarter Earnings of 2021
October 29, 2021 16:07 ET | Paul Mueller Company
SPRINGFIELD, Mo., Oct. 29, 2021 (GLOBE NEWSWIRE) -- Paul Mueller Company (OTC: MUEL) today announced earnings for the quarter ended September 30, 2021. PAUL MUELLER COMPANYNINE-MONTH...
TIP_link_300x300.jpg
Hematuria Treatment Market Size ($1,103.61Mn by 2028) Led by Urinary Tract Infections (17.31% Market Share in 2020) Impact of Coronavirus Outbreak and Global Analysis & Forecast by TheInsightPartners.com
October 29, 2021 13:45 ET | The Insight Partners
New York, Oct. 29, 2021 (GLOBE NEWSWIRE) -- Hematuria Treatment Market: Key InsightsAccording to our new research study on Hematuria Treatment Market Size and Forecast to 2028 - COVID-19 Impact and...
TIP_link_300x300.jpg
Cardiometabolic Diseases Market Size ($121,804.49Mn by 2028) Lead by Cardiovascular Disease (3.9% CAGR) Impact of Coronavirus Outbreak and Global Analysis & Forecast by TheInsightPartners.com
October 29, 2021 09:54 ET | The Insight Partners
New York, Oct. 29, 2021 (GLOBE NEWSWIRE) -- Cardiometabolic Diseases Market: Key InsightsAccording to our new research study on Cardiometabolic Diseases Market Size and Forecast to 2028 - COVID-19...
TIP_link_300x300.jpg
Sexual Wellness Market Size ($81,394.49Mn by 2028) Lead by Capsules Segment (6.6% CAGR) Impact of Coronavirus Outbreak and Global Analysis & Forecast by TheInsightPartners.com
October 29, 2021 09:31 ET | The Insight Partners
New York, Oct. 29, 2021 (GLOBE NEWSWIRE) -- Sexual Wellness Market: Key InsightsAccording to our new research study on Sexual Wellness Market Size and Forecast to 2028 - COVID-19 Impact and Global...
XBiotech logo
XBiotech to Launch Novel Candidate Therapy for Stroke
October 28, 2021 11:59 ET | XBiotech Inc.
AUSTIN, Texas, Oct. 28, 2021 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ: XBIT) announced today its plan to commence a randomized, placebo-controlled clinical study to test its new True Human™ antibody...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Spectrum and loanDepot and Encourages Investors to Contact the Firm
October 27, 2021 21:00 ET | Bragar Eagel & Squire
NEW YORK, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...